Agena Bioscience is ready to make its mark on the liquid biopsy landscape with two new lung and colon cancer test panels. The CE-IVD marked panels incorporate Agena's UltraSEEK chemistry for mutation detection and are intended for use on its MALDI-TOF-based MassArray Dx Analyzer 4 platform, which is currently sold in Europe, the US and the Asia-Pacific region. ([A#MT103965/])
The MassArray Dx Lung Panel and MassARRAY Dx Colon Panel have been used in pre-release for certain customers in the...